scispace - formally typeset
X

Xiaohu Wang

Publications -  8
Citations -  16

Xiaohu Wang is an academic researcher. The author has contributed to research in topics: Medicine & Pharmacokinetics. The author has an hindex of 1, co-authored 2 publications receiving 2 citations.

Papers
More filters
Journal ArticleDOI

Schisandrin A from Schisandra chinensis Attenuates Ferroptosis and NLRP3 Inflammasome-Mediated Pyroptosis in Diabetic Nephropathy through Mitochondrial Damage by AdipoR1 Ubiquitination

TL;DR: It is revealed that Schisandrin A from Schisandra chinensis attenuates ferroptosis and NLRP3 inflammasome-mediated pyroptotic in DN by AdipoR1/AMPK-ROS/mitochondrial damage and is a possible therapeutic option for DN or other diabetes.
Journal ArticleDOI

Anthraxolite Evolution and Vanadium Enrichment Mechanism in the Tanjianshan Group, Upper Ordovician in the Northern Qaidam Basin

TL;DR: In this article, the authors examined the interaction between organic matter (OM) and metals, but the paragenesis of anthraxolite and mechanism enrichment of vanadium (V) need further study.
Journal ArticleDOI

Predictive performance and verification of physiologically based pharmacokinetic model of propylthiouracil

TL;DR: The PBPK model of PTU was successfully developed, externally validated, and applied to tissue distribution prediction and special population extrapolation, which provides a reference for clinical individualized drug administration and evaluation.
Journal ArticleDOI

Paragenesis mechanism of anthraxolite and vanadium: A case study of the Tanjianshan Group in the Northern Margin of the Qaidam Basin

TL;DR: Chenglin Liu et al. as discussed by the authors proposed a method for the extraction of petroleum resources and prospecting in China, which is based on the work of the State Key Laboratory of Petroleum Resource and Prospecting.
Journal ArticleDOI

Development and Validation of Physiologically Based Pharmacokinetic Model of Levetiracetam to Predict Exposure and Dose Optimization in Pediatrics.

TL;DR: In this article , the authors used the physiologically based pharmacokinetic (PBPK) model to predict changes in plasma exposure of Lev in pediatric patients and to provide recommendations for dose adjustment.